Deconstructing fibrin(ogen) structure
- PMID: 39536819
- PMCID: PMC11786978
- DOI: 10.1016/j.jtha.2024.10.024
Deconstructing fibrin(ogen) structure
Abstract
Fibrinogen and its insoluble degradation product fibrin are pivotal plasma proteins that play important roles in blood coagulation, wound healing, and immune responses. This review highlights research from the last 24 months connecting our progressing view of fibrin(ogen)'s structure, and in particular its conformational flexibility and posttranslational modifications, to its (patho)physiologic roles, molecular interactions, mechanical properties, use as a biomaterial, and potential as a therapeutic target. Recent work suggests that fibrinogen structure is highly dynamic, sampling multiple conformations, which may explain its myriad physiologic functions and the presence of cryptic binding sites. Investigations into fibrin clot structure elucidated the impact of posttranslational modifications, therapeutic interventions, and pathologic conditions on fibrin network morphology, offering insights into thrombus formation and embolization. Studies exploring the mechanical properties of fibrin reveal its response to blood flow and platelet-driven contraction, offering implications for clot stability and embolization risk. Moreover, advancements in tissue engineering leverage fibrin's biocompatibility and customizable properties for diverse applications, from wound healing to tissue regeneration and biomaterial interactions. These findings underscore the structural origins of fibrin(ogen)'s multifaceted roles and its potential as a target for therapeutic interventions.
Keywords: blood clot; fibrin; fibrinogen; mechanics; tissue engineering.
Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interests There are no competing interests to disclose.
Similar articles
-
Integrated cross-linking by TG2 and FXIII generates hepatoprotective fibrin(ogen) deposits in injured liver.Blood. 2025 May 22;145(21):2507-2517. doi: 10.1182/blood.2024026938. Blood. 2025. PMID: 40009455
-
Acetaldehyde exposure alters fibrin polymerization, fibrinolysis, and fibrin network structure in vitro.Res Pract Thromb Haemost. 2025 Jun 6;9(4):102921. doi: 10.1016/j.rpth.2025.102921. eCollection 2025 May. Res Pract Thromb Haemost. 2025. PMID: 40678355 Free PMC article.
-
Clot-Targeted Nanogels for Dual-Delivery of AntithrombinIII and Tissue Plasminogen Activator to Mitigate Disseminated Intravascular Coagulation Complications.ACS Nano. 2024 Jun 18;18(24):15517-15528. doi: 10.1021/acsnano.4c00162. Epub 2024 Jun 5. ACS Nano. 2024. PMID: 38836363 Free PMC article.
-
Pharmacological interventions for the prevention of bleeding in people undergoing elective hip or knee surgery: a systematic review and network meta-analysis.Cochrane Database Syst Rev. 2024 Jan 16;1(1):CD013295. doi: 10.1002/14651858.CD013295.pub2. Cochrane Database Syst Rev. 2024. PMID: 38226724 Free PMC article.
-
Platelet-Rich Fibrin and Soft Tissue Wound Healing: A Systematic Review.Tissue Eng Part B Rev. 2017 Feb;23(1):83-99. doi: 10.1089/ten.TEB.2016.0233. Epub 2016 Oct 10. Tissue Eng Part B Rev. 2017. PMID: 27672729
Cited by
-
Homocysteinylation of Fibrinogen: A Post-Translational Link to Thrombosis.Int J Mol Sci. 2025 Jun 7;26(12):5471. doi: 10.3390/ijms26125471. Int J Mol Sci. 2025. PMID: 40564934 Free PMC article. Review.
-
Smart Thrombosis Care: The Rise of Closed-Loop Diagnosis-to-Treatment Nano Systems.Int J Nanomedicine. 2025 Jun 19;20:7851-7868. doi: 10.2147/IJN.S530884. eCollection 2025. Int J Nanomedicine. 2025. PMID: 40551977 Free PMC article. Review.
-
Clot formation, structure, and fibrinolysis of plasma from pancreatic cancer patients.J Thromb Thrombolysis. 2025 Jul 14. doi: 10.1007/s11239-025-03118-x. Online ahead of print. J Thromb Thrombolysis. 2025. PMID: 40658336
-
Clot formation, structure, and fibrinolysis of pancreatic cancer patients.Res Sq [Preprint]. 2025 Feb 11:rs.3.rs-5868575. doi: 10.21203/rs.3.rs-5868575/v1. Res Sq. 2025. Update in: J Thromb Thrombolysis. 2025 Jul 14. doi: 10.1007/s11239-025-03118-x. PMID: 39989974 Free PMC article. Updated. Preprint.
-
Platelets as drivers of immunothrombosis in rheumatic diseases.Nat Rev Rheumatol. 2025 Aug;21(8):478-493. doi: 10.1038/s41584-025-01276-z. Epub 2025 Jul 7. Nat Rev Rheumatol. 2025. PMID: 40624395 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources